Chemotherapy drug shortages in the U.S. — The recurring nightmare
The shortage of cytarabine, a drug critical to the cure of one form of leukemia, acute myeloid leukemia, entered public consciousness in early 2011. With cytarabine-based therapy, the cure rate is 40%; without it there are no cures. This resulted… Continue Reading